Journal Articles
Featured Topics
Lead story
Other featured articles
-
Impacts on the U.S. Macroeconomy of Mandatory Business Closures in Response to the COVID-19 Pandemic
A mandatory business closure over three months results in a 20.3% decline of U.S. GDP on an annual basis, or $4.3 trillion, and an employment decline of 22.4%, representing 35.3 million workers.
Posted in -
Is the Choice of Cost-Effectiveness Threshold in Cost-Utility Analysis Endogenous to the Resulting Value of Technology? A Systematic Review
This analysis highlights that most cost-utility analyses that cite high cost-effectiveness thresholds also result in greater incremental cost-effectiveness ratios for the novel interventions that they investigate.
Posted in -
Blood‐Based Biomarkers for Alzheimer’s Pathology and the Diagnostic Process for a Disease‐Modifying Treatment: Projecting the Impact on the Cost and Wait Times
Blood‐based biomarker tests are a promising tool to improve triaging Alzheimer’s disease at the primary care level.
Posted in -
The “Advancing American Kidney Health” Executive Order: Challenges and Opportunities for the Large Dialysis Organizations
This perspective in the American Journal of Kidney Diseases examines how the “Advancing American Kidney Health” Executive Order (AAKH) might reshape the US dialysis market.
Posted in
ADDITIONAL JOURNAL ARTICLES
-
The Need to More Effectively Regulate End Markets: A Primary Public Health Lesson of the U.S. Vaping Associated Lung Injury Outbreak
To begin, the designation of END products as “tobacco products” rather than “medical products” meant manufacturers did not have to meet pharmaceutical safety standards.
Categorized in -
Uptake of Infliximab Biosimilars Among the Medicare Population
Two years after launch, biosimilars for rheumatoid arthritis and other lifelong conditions captured little market share.
Categorized in -
Lifetime Burden of Adult Congenital Heart Disease in the USA Using a Microsimulation Model
There is a significant burden of disease among individuals with CHD; the disease affects quality of life, disability, life expectancy, medical spending, chronic disease, as well as employment and education outcomes.
Categorized in -
The State of the Science in Opioid Policy Research
A review of 145 opioid policy evaluation studies found that greater adoption of more rigorous study designs and statistical methods is warranted.
-
Sex, Race, and Age Differences in Prevalence of Dementia in Medicare Claims and Survey Data
This study provides the first comparison of trends in dementia prevalence in the U.S. population using 3 different dementia ascertainments/data sources. They found there are still substantial differences across measures in dementia prevalence among Blacks and Hispanics.
-
State Approaches to Tackling the Opioid Crisis Through the Health Care System
States have implemented multiple strategies to enhance the capacity and quality of treatment services for opioid use disorder.